查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1936587

內視鏡治療設備市場機會、成長要素、產業趨勢分析及2026年至2035年預測

Endotherapy Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球內視鏡設備市場預計到 2025 年將達到 56 億美元，到 2035 年將達到 117 億美元，年複合成長率為 7.6%。

內視鏡治療器材市場-IMG1

推動市場成長的關鍵因素包括微創治療方法的加速普及、治療性內視鏡技術的快速創新以及門診和日間護理機構的興起。內視鏡治療設備是專門設計的器械，用於輔助透過內視鏡途徑進行的治療操作，無需大型手術切口即可進行體內治療。這些設備使臨床醫生能夠進行標靶治療性介入，同時提高治療精度並縮短患者恢復時間。醫療保健系統手術量的不斷成長進一步推動了對先進內視鏡治療解決方案的需求。更高的可視性、設備柔軟性、能量傳輸系統以及自動化技術的持續進步正在提高手術精度和患者安全性。這些進步正在擴大內視鏡可治療的疾病範圍，並減少對傳統手術的依賴。持續的技術升級也促進了設備的更新換代，因為醫療保健機構優先考慮能夠帶來更好臨床效果和更高營運效率的現代化系統。

市場覆蓋範圍
開始年份 2025
預測年份 2026-2035
起始值 56億美元
預測金額 117億美元
複合年成長率 7.6%

內視鏡治療平台日趨精密，融合了高清成像、增強對比視覺化和先進光學技術。這些特性有助於提高檢測能力和治療精準度，從而增強臨床信心並提高手術成功率。更清晰的視覺化效果在醫療機構推廣應用方面持續發揮核心作用。

2025年，消化器官系統及配件市場佔有率將達到56.4%，這主要得益於持續高企的手術量以及治療工具在常規內視鏡診療中的廣泛應用。胃腸道內視鏡治療在診斷和介入治療中的廣泛應用，使該細分市場保持主導。內視鏡治療方法的日益普及也持續支撐著該類別下專用配件和器械的持續需求。

預計到2025年，醫院市場將佔據54.6%的市場佔有率，並在2026年至2035年間達到62億美元。醫院需要處理各種各樣的患者病例，並進行大量複雜的多學科手術，從而對先進的內視鏡治療技術產生了持續的需求。這些機構擁有完善的內視鏡基礎設施、先進的診斷影像系統和專業的臨床知識，這增強了它們在市場推廣方面的優勢。

2025年，美國內視鏡市場價值將達23億美元。強大的報銷體系和支持內視鏡檢查的醫療保健資金結構繼續推動對現代內視鏡設備的投資，從而在所有醫療保健機構中保持較高的使用率。

目錄

第1章調查方法

  • 研究途徑
  • 品質保證
    • GMI人工智慧政策與資料完整性承諾
      • 資訊來源完整性通訊協定
  • 調查可追溯性和可靠性評分
    • 勘測和步道組成部分
    • 評分組成部分
  • 數據收集
    • 主要資訊的部分列表
  • 資料探勘資訊來源
    • 付費資訊來源
      • 區域資訊來源
  • 基本估計值與計算
    • 兩種方法的基準年計算均適用。
  • 預測模型
    • 量化市場影響分析
      • 生長參數對預測值的數學影響
  • 研究透明度附錄
    • 資訊來源歸屬框架
    • 品質保證指標
    • 對信任的承諾

第2章執行摘要

第3章業界考察

  • 生態系分析
  • 產業影響因素
    • 促進要素
      • 胃腸道疾病盛行率不斷上升
      • 對微創手術的需求日益成長
      • 頻繁的內視鏡檢查
      • 內視鏡設備的技術進步
    • 產業潛在風險與挑戰
      • 先進內視鏡治療設備高成本
      • 手術相關併發症的風險
    • 市場機遇
      • 一次性內視鏡治療設備的應用日益廣泛
      • 機器人技術和人工智慧在內視鏡治療中的融合
  • 成長潛力分析
  • 監管環境
    • 北美洲
    • 歐洲
    • 亞太地區
  • 科技趨勢
    • 當前技術趨勢
    • 新興技術
  • 救贖方案
  • 未來市場趨勢
  • 價值鏈分析
  • 定價分析
  • Start-Ups場景
  • 消費者洞察
  • 波特五力分析
  • PESTEL 分析
  • 差距分析

第4章 競爭情勢

  • 介紹
  • 企業矩陣分析
  • 公司市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 競爭定位矩陣
  • 主要市場公司的競爭分析
  • 重大進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章 2022-2035年按產品分類的市場估算與預測

  • 消化系統醫療設備及配件
    • 切片檢查鉗
      • 一次性切片檢查鉗
      • 可重複使用的切片檢查鉗
      • 熱切片檢查鉗
    • 針頭
      • 超音波超音波引導下細針穿刺（FNA）針
      • 超音波超音波引導下細針穿刺切片（FNB）針
      • 其他注射針
    • 內視鏡黏膜下剝離術（ESD）刀
      • 帶針的刀
      • 絕緣刀尖
    • 息肉切除勒除器
    • 血夾
    • 夾鉗
    • 止血鉗
    • 硬化治療針
    • 其他胃腸道醫療設備及配件
  • 內視鏡逆行性胰造影（ERCP）器材及配件
    • 金屬支架
    • 括約肌切開術
    • 導管導引線
    • 導管
      • 引導管
      • 擴張導管
      • 引流導管
      • 其他導管
    • 塑膠支架
    • 球囊擴張
    • 吸盤籃
    • 吸球
    • 其他ERCP器材和配件
  • 其他產品

第6章 按應用領域分類的市場估算與預測，2022-2035年

  • 胃腸內視鏡檢查
  • 腹腔鏡
  • 關節鏡
  • 泌尿系統內視鏡治療
  • 支氣管鏡檢查
  • 其他用途

7. 依最終用途分類的市場估計與預測，2022-2035 年

  • 醫院
  • 門診手術中心
  • 其他用途

第8章 2022-2035年各地區市場估算與預測

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第9章：公司簡介

  • B. BRAUN
  • Boston Scientific
  • CONMED
  • Cook Medical
  • Endo-Med
  • FUJIFILM
  • Johnson &Johnson
  • KARL STORZ
  • MI Tech
  • Medtronic
  • MICRO-TECH
  • OLYMPUS
  • Smith+Nephew
  • Stryker
  • TAEWOONG MEDICAL
簡介目錄
Product Code: 3782

The Global Endotherapy Devices Market was valued at USD 5.6 billion in 2025 and is estimated to grow at a CAGR of 7.6% to reach USD 11.7 billion by 2035.

Endotherapy Devices Market - IMG1

Market expansion is driven by the increasing shift toward minimally invasive treatment approaches, rapid innovation in therapeutic endoscopy technologies, and the growing number of outpatient and ambulatory care facilities. Endotherapy devices are specialized instruments designed to support therapeutic procedures performed through endoscopic access, enabling internal treatment without large surgical incisions. These devices allow clinicians to perform targeted therapeutic interventions with improved accuracy and reduced patient recovery time. Rising procedural volumes across healthcare systems are reinforcing demand for advanced endotherapy solutions. Continuous improvements in visualization quality, device flexibility, energy delivery systems, and automation are enhancing procedural precision and patient safety. These advancements are broadening the range of conditions that can be managed endoscopically, reducing reliance on conventional surgery. Ongoing technology upgrades are also contributing to replacement demand, as healthcare providers prioritize modern systems that deliver better clinical outcomes and operational efficiency.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$5.6 Billion
Forecast Value$11.7 Billion
CAGR7.6%

Endotherapy platforms are becoming increasingly sophisticated, integrating high-definition imaging, enhanced contrast visualization, and advanced optical technologies. These features support improved detection capabilities and more accurate therapeutic delivery, strengthening clinical confidence and improving procedural success rates. Enhanced visualization continues to play a central role in expanding adoption across healthcare facilities.

The gastrointestinal devices and accessories segment accounted for 56.4% share in 2025, supported by consistently high procedure volumes and widespread use of therapeutic tools in routine endoscopic care. The segment maintains its leadership position due to the broad application of gastrointestinal endotherapy across diagnostic and interventional procedures. Growing utilization of endoscopic treatment methods continues to support sustained demand for specialized accessories and devices within this category.

The hospitals segment generated 54.6% share in 2025 and is expected to reach USD 6.2 billion during 2026-2035. Hospitals manage a wide range of patient cases and perform a high volume of complex and multidisciplinary procedures, driving consistent demand for advanced endotherapy technologies. These facilities are equipped with comprehensive endoscopy infrastructure, advanced imaging systems, and specialized clinical expertise, reinforcing their dominance in market adoption.

U.S. Endotherapy Devices Market was valued at USD 2.3 billion in 2025. Strong reimbursement coverage for endoscopic procedures and supportive healthcare funding structures continue to encourage investment in modern endotherapy equipment, sustaining high utilization rates across care settings.

Key companies active in the Global Endotherapy Devices Market include Medtronic, OLYMPUS, Boston Scientific, KARL STORZ, FUJIFILM, Johnson & Johnson, Cook Medical, CONMED, Smith+Nephew, Stryker, B. BRAUN, Endo-Med, MICRO-TECH, M.I. Tech, and TAEWOONG MEDICAL. These companies maintain competitive positions through innovation, product breadth, and global distribution networks. To strengthen their presence, companies in the endotherapy devices sector focus heavily on continuous product innovation and technological differentiation. Strategic investments in advanced imaging, energy-based tools, and device miniaturization enhance clinical performance and usability. Manufacturers are expanding geographic reach through partnerships, acquisitions, and distribution agreements to access high-growth markets. Training programs and physician education initiatives are used to drive adoption and long-term customer loyalty.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 Application trends
    • 2.2.4 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of gastrointestinal disorders
      • 3.2.1.2 Growing demand for minimally invasive procedures
      • 3.2.1.3 High volume of endoscopic procedures
      • 3.2.1.4 Technological advancements in endoscopic devices
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of advanced endotherapy devices
      • 3.2.2.2 Risk of procedure-related complications
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing adoption of single-use endotherapy devices
      • 3.2.3.2 Integration of robotics and AI in endotherapy
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario
  • 3.7 Future market trends
  • 3.8 Value chain analysis
  • 3.9 Pricing analysis
  • 3.10 Start-up scenarios
  • 3.11 Consumer insights
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis
  • 3.14 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Gastrointestinal devices & accessories
    • 5.2.1 Biopsy forceps
      • 5.2.1.1 Single-use biopsy forceps
      • 5.2.1.2 Reusable biopsy forceps
      • 5.2.1.3 Hot biopsy forceps
    • 5.2.2 Injection needles
      • 5.2.2.1 EUS-guided FNA (fine needle aspiration) needles
      • 5.2.2.2 EUS-guided FNB (fine needle biopsy) needles
      • 5.2.2.3 Other injection needles
    • 5.2.3 Endoscopic submucosal dissection (ESD) knives
      • 5.2.3.1 Needle-tipped knives
      • 5.2.3.2 Insulation-tipped knives
    • 5.2.4 Polypectomy snares
    • 5.2.5 Hemoclips
    • 5.2.6 Graspers
    • 5.2.7 Hemostasis forceps
    • 5.2.8 Sclerotherapy needles
    • 5.2.9 Other gastrointestinal devices & accessories
  • 5.3 Endoscopic retrograde cholangiopancreatography (ERCP) devices & accessories
    • 5.3.1 Metal stents
    • 5.3.2 Sphincterotome
    • 5.3.3 Guide wire
    • 5.3.4 Catheter
      • 5.3.4.1 Guiding catheter
      • 5.3.4.2 Dilation catheter
      • 5.3.4.3 Drainage catheter
      • 5.3.4.4 Other catheters
    • 5.3.5 Plastic stents
    • 5.3.6 Balloon dilation
    • 5.3.7 Extraction basket
    • 5.3.8 Extraction balloon
    • 5.3.9 Other ERCP devices & accessories
  • 5.4 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Gastrointestinal endoscopy
  • 6.3 Laparoscopy
  • 6.4 Arthroscopy
  • 6.5 Urology endotherapy
  • 6.6 Bronchoscopy
  • 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 B. BRAUN
  • 9.2 Boston Scientific
  • 9.3 CONMED
  • 9.4 Cook Medical
  • 9.5 Endo-Med
  • 9.6 FUJIFILM
  • 9.7 Johnson & Johnson
  • 9.8 KARL STORZ
  • 9.9 M.I. Tech
  • 9.10 Medtronic
  • 9.11 MICRO-TECH
  • 9.12 OLYMPUS
  • 9.13 Smith+Nephew
  • 9.14 Stryker
  • 9.15 TAEWOONG MEDICAL